What to ask
Questions to take to an assessment
Keep the questions that fit your concern. Bring the list to an assessment and ask for replies you can explain back yourself.
Start with your problem.
What might explain the symptoms? What information is still missing? What care options fit the problem? What would make an in-person exam useful?
Ask what the medicine is and whether it is allowed.
The US drug-review agency is FDA, which stands for Food and Drug Administration.
Is the proposed medicine FDA-approved?
For BPC-157, the September 2026 answer was no. FDA approval finding
If the proposal involves compounding, that means making a medicine to order.
Names such as BPC-157 acetate and BPC-157 free base refer to different substances.
What is the full substance name? Does it match the label and test report? Who would make it? What rule permits the pharmacy to prepare it to order?
Ask what the evidence actually shows.
Which human study fits this problem? Was there a comparison group? What did the result measure? What remains unknown about harm?
Keep a study link and the explanation together.
Ask about checks and responsibility.
What testing was done on the batch? Who can explain the test report? FDA batch-testing concerns
Which state licence covers this visit? Which pharmacy would make or send a medicine? Who tracks tests and answers later questions?
Close the gaps in the bill and the plan.
What is the full assessment cost? What is extra? What do I owe if the decision is to prescribe nothing? How do repeat payments end?
When is the review? Who handles a new problem? How do you get a copy of the plan?